Adma Biologics Inc. (ADMA)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Adma Biologics (ADMA) settling at $9.01, representing a -1.53% change from its previous close.
Why Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?
Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock?
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade
Adma Biologics (ADMA) closed the most recent trading day at $9.63, moving 15% from the previous trading session.
Down 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Adma Biologics (ADMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
New Strong Buy Stocks for March 25th
EQT, BCBP, FIX, PAAS and ADMA have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2026.
New Strong Buy Stocks for March 23rd
LCUT, EFXT, MGA, ADMA and JLL have been added to the Zacks Rank #1 (Strong Buy) List on March 23, 2026.
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $15.02, denoting a +1.01% move from the preceding trading day.
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
ADMA Biologics Inc $ADMA Shares Bought by B Group Inc.
B Group Inc. grew its stake in ADMA Biologics Inc (NASDAQ: ADMA) by 4.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,412,542 shares of the biotechnology company's stock after purchasing an additional 95,000 shares during the quarter. ADMA Biologics
Why the Market Dipped But Adma Biologics (ADMA) Gained Today
Adma Biologics (ADMA) concluded the recent trading session at $15.15, signifying a +1.03% move from its prior day's close.
4 Biotech Stocks to Watch for Potential Upside in 2026
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position TERN, ADMA, ANIP and LQDA in this volatile sector.
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Adma Biologics (ADMA) reached $14.99 at the closing of the latest trading day, reflecting a -4.34% change compared to its last close.
